Project: Evaluating tumor bound chemokines for cancer immunotherapy
- project duration
- 01-OCT-02 – 30-SEP-04
- The project aims at evaluating the use of killed cancer cells as whole cell vaccines, while painting the cells with antibody molecules fused to chemokines. The chemokines studied are expected to be specific for dendritic cells in the skin. The project will monitor if the dendritic cells process the antigen and present it to the T-cells in the lymph nodes, and will monitor the nature of the immune response as well as the therapeutic potential of this study of anti-cancer vaccine.